Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ACSS2 Regulates HIF-2α Degradation through the E3-Ubiquitin Ligase MUL1 in Clear Cell Renal Cell Carcinoma

ABSTRACT:

ORGANISM(S): Mus Musculus

TISSUE(S): Tumor Cells

DISEASE(S): Cancer

PROVIDER: ST002241 | MetabolomicsWorkbench |

REPOSITORIES: MetabolomicsWorkbench

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	mwtab	Other

Items per page:

1 - 1 of 1

Similar Datasets

TRIM65 promotes renal cell carcinoma through ubiquitination and degradation of BTG3.

Project description: Not available

| S-EPMC11111765 | biostudies-literature

MPP7 inhibits tumor metastasis through promoting snail degradation in clear cell renal cell carcinoma.

Project description: Not available

| S-EPMC12781724 | biostudies-literature

An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma

Project description:Changes in cellular metabolism contribute to the development and progression of tumors, and can render tumors vulnerable to interventions. However, studies of human cancer metabolism remain limited due to technical challenges of detecting and quantifying small molecules, the highly interconnected nature of metabolic pathways, and the lack of designated tools to analyze and integrate metabolomics with other âomics data. Our study generates the largest comprehensive metabolomics dataset on a single cancer type, and provides a significant advance in integration of metabolomics with sequencing data. Our results highlight the massive re-organization of cellular metabolism as tumors progress and acquire more aggressive features. The results of our work are made available through an interactive public data portal for cancer research community. 10 RNA samples from human ccRCC tumors analyzed from the high glutathione cluster

2016-03-08 | E-GEOD-74734 | biostudies-arrayexpress

GPX8 regulates clear cell renal cell carcinoma tumorigenesis through promoting lipogenesis by NNMT.

Project description: Not available

| S-EPMC9903620 | biostudies-literature

ARRDC3 regulates the targeted therapy sensitivity of clear cell renal cell carcinoma by promoting AXL degradation.

Project description: Not available

| S-EPMC11005801 | biostudies-literature

ACSS2 Regulates HIF-2α Degradation through the E3-Ubiquitin Ligase MUL1 in Clear Cell Renal Cell Carcinoma

Project description:ACSS2 is a key contributor to the acetyl-CoA pool and has a role in supporting biosynthetic processes, as well as acetylation. To investigate the role of ACSS2 in regulating chromatin accessibility in ccRCC, we performed ATAC-seq on 786-O cells treated with DMSO or ACSS2i for 24 hours.

2023-05-26 | GSE204947 | GEO

IKBKE regulates renal cell carcinoma progression and sunitinib resistance through the RRM2-AKT pathway.

Project description: Not available

| S-EPMC11628342 | biostudies-literature

SHARPIN regulates the development of clear cell renal cell carcinoma by promoting von Hippel-Lindau protein ubiquitination and degradation.

Project description: Not available

| S-EPMC8486188 | biostudies-literature

FOXD1 regulates cell division in clear cell renal cell carcinoma.

Project description: Not available

| S-EPMC7988646 | biostudies-literature

MDH2 regulates the sensitivity of clear cell renal cell carcinoma to ferroptosis through its interaction with FSP1.

Project description: Not available